1-[(2R,3R,4S,5R)-5-acetyl-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-aminopyrimidin-2-one

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-[(2R,3R,4S,5R)-5-acetyl-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-aminopyrimidin-2-one
• 化学式: C₁₁H₁₅N₃O₆
• 分子量: 285.25
• InChiKey: MTRDIPBJXPOSNU-LOKLDPHHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.1
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  146
• 氢给体数：
  4
• 氢受体数：
  6

文献信息

• 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication
  申请人：——

  公开号：US20030236216A1

  公开（公告）日：2003-12-25

  The present invention relates to the use of nucleoside derivatives of formula I 1 wherein B signifies a 9-purinyl residue B1 of formula 2 or a 1-pyrimidyl residue B2 of formula 3 wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof; for the treatment of diseases mediated by the Hepatitis C Virus (HCV), for the preparation of a medicament for such treatment and to pharmaceutical compositions containing such compounds.

  本发明涉及使用公式I1的核苷衍生物，其中B表示公式2的9-嘌呤基残基B1或公式3的1-嘧啶基残基B2，其中符号如规范中所定义，并且其药物可接受的盐；用于治疗由丙型肝炎病毒（HCV）介导的疾病，用于制备用于该治疗的药物以及含有这些化合物的制药组合物。
• 4'-SUBSTITUDED NUCLEOSIDES FOR THE TREATMENT OF DISEASES MEDIATED BY THE HEPATITIS C VIRUS
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP1404347B1

  公开（公告）日：2006-01-18
• 4'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION
  申请人：Devos Rene Robert

  公开号：US20100003213A1

  公开（公告）日：2010-01-07

  The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.
• 4'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
  申请人：Martin Joseph Armstrong

  公开号：US20100004192A1

  公开（公告）日：2010-01-07

  The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.
• US6784166B2
  申请人：——

  公开号：US6784166B2

  公开（公告）日：2004-08-31